๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 451 Beijing 25 Shenzhen 23 Zhongshan 17 Nanning 17
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281 Clear sponsor filter
Site location
Guangzhou451 Beijing25 Shenzhen23 Zhongshan17 Nanning17
All 55 locations
Target enrolment
to
490 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
TEER In dynaMic sEvere Functional Mitral Regurgitation (TIMER)
NCT07197021Mitral Regurgitation Functional
Sun Yat-sen University
Not applicable
540
Guangzhou
2027-01-01
Not yet open
Study on Improving Blood Glucose Homeostasis With Dorzagliatin Tablets in the Treatment of Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal Insufficiency
NCT07786571Type 2 Diabetes Mellitus (T2DM), Chronic Renal Insufficiency, Chronic Kidney Disease (Stages 3b-5), Glucose Homeostasis
Sun Yat-sen University
Not applicable
206
Guangzhou
2026-12-01
Not yet open
Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer
NCT07714447CRC (Colorectal Cancer), BRAF
Sun Yat-sen University
Phase 2
91
Guangzhou
2026-11-30
Not yet open
Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negative Breast Cancer)
NCT07255612Breast Cancer
Sun Yat-sen University
Phase 2
29
Guangzhou
2026-11-04
Not yet open
Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma
NCT07824856Nasopharyngeal Carcinoma, Neoplasm Metastasis, Lung Metastases, Liver Metastases
Sun Yat-sen University
Phase 2
138
Guangzhou
2026-10
Not yet open
Full-wrap Versus Conventional Suspension for Reducing Soft Palate Injury Rate in Transoral Surgery
NCT07552545Adenoid Hypertrophy, Tonsillar Hypertrophy, Nasopharyngeal Diseases, Nasopharyngeal Tumors
Sun Yat-sen University
Not applicable
138
Zhuhai
2026-09-30
Not yet open
Trastuzumab Rezetecan and Carboplatin ยฑ Bevacizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-sensitive Recurrent Ovarian Cancer
NCT07776171Ovarian Cancer, Platinum Sensitive Ovarian Cancer (PSOC)
Sun Yat-sen University
Phase 2
176
Guangzhou
2026-09-30
Not yet open
Effects of Different PICC Catheterization Methods: A Multicenter Randomized Controlled Trial
NCT07791719Cancer Patients
Sun Yat-sen University
Not applicable
801
Guangzhou
2026-09-10
Not yet open
Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II Study
NCT07756190Nasopharyngeal Carcinoma (NPC), Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2
28
Guangzhou
2026-09-01
Not yet open
Sonrotoclax, Zanubrutinib and Rituximab in Previously Untreated Patients With Follicular Lymphoma
NCT07550855Follicular Lymphoma (FL)
Sun Yat-sen University
Phase 2
52
Guangzhou
2026-09-01
Not yet open
Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell Carcinoma
NCT07766889Oral Squamous Cell Carcinoma, Head and Neck Cancer, Locally Advanced Head and Neck Cancer, Neoadjuvant Therapy
Sun Yat-sen University
Phase 2
32
Guangzhou
2026-09-01
Not yet open
Radiotherapy Combined With Capeox Chemotherapy, Sintilimab and Suvemcitug in Locally Advanced pMMR Rectal Cancer:a Prospective Clinical Trial
NCT07774754Rectal Cancer
Sun Yat-sen University
Phase 2
18
Guangzhou
2026-09-01
Not yet open
Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma
NCT07701681ESCC, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-sen University
Phase 2
75
Guangzhou
2026-08-31
Recruiting
Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma
NCT07796789Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 3
204
Guangzhou, Changsha, Fuzhou
2026-08-30
Not yet open
Culmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain Metastases
NCT07745257HR-positive, HER2-negative Metastatic Breast Cancer With Brain Metastases
Sun Yat-sen University
Phase 2
40
Guangzhou, Shijiazhuang, Anyang, Zhengzhou, Nanjing, Nanchang, Dalian, Chengdu
2026-08-28
Not yet open
VIPeerAgent for Adolescent Mental Health
NCT07778758Youth Mental Health, Psychological Distress in Adolescents and Young Adults, Early Intervention
Sun Yat-sen University
Not applicable
234
Guangzhou
2026-08-20
Not yet open
Golidocitinib Plus Anthracycline-based Therapy for Untreated Nodal T-follicular Helper (TFH) Cell Lymphoma
NCT07753642Nodal T-follicular Helper Cell Lymphoma
Sun Yat-sen University
Phase 2
47
Guangzhou
2026-08-15
Not yet open
Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile Cancer
NCT07767266Penile Cancer, Penile Squamous Cell Carcinoma (PSCC)
Sun Yat-sen University
Phase 2
29
Guangzhou
2026-08-15
Recruiting
Ivosidenib Plus mFOLFOXIRI and Celecoxib for BRAF-targeted Therapy-refractory BRAF V600E-mutant Colorectal Cancer Patients
NCT07809893Colorectal Cancer
Sun Yat-sen University
Phase 2
45
Guangzhou
2026-08-10
Not yet open
Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma
NCT07064902Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University
Phase 2
48
Xiamen, Guangzhou, Guilin
2026-08-01
Not yet open
Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC
NCT07674524Non-Small Cell Lung Cancer (NSCLC), Hyperlipidemia, ALK Gene Mutation, ALK-positive
Sun Yat-sen University
Observational
160
Guangzhou
2026-08-01
Recruiting
Neoadjuvant Chemoradiotherapy Combined With CTLA-4 Monoclonal Antibody Plus PD-1 Monoclonal Antibody for Locally Advanced Esophageal Cancer
NCT07751055Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-sen University
Phase 2
51
Guangzhou
2026-08-01
Recruiting
Culmerciclib in HR+/HER2+ Advanced Breast Cancer
NCT07732491Breast Cancer, Metastastic Breast Cancer, HER2+ Advanced Breast Cancer
Sun Yat-sen University
Phase 2
35
Guangzhou
2026-08-01
Not yet open
Teprotumumab N01 Versus Methylprednisolone After Urgent Orbital Decompression for Dysthyroid Optic Neuropathy
NCT07594912Thyroid Eye Disease, TED, Graves Ophthalmopathy, Optic Neuropathy
Sun Yat-sen University
Phase 2
60
Guangzhou
2026-08
Not yet open
FOLFIRI Plus Bevacizuamb and QL1706 in Second-Line Treatment for mCRC
NCT07729605Colorectal Cancer Metastatic, Microsatellite Stable (MSS) Colorectal Cancer (CRC)
Sun Yat-sen University
Phase 3
270
Guangzhou
2026-07-30
Recruiting
Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal Carcinoma
NCT07661771Non-metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
568
Dongguan, Foshan, Guangzhou, Shenzhen, Zhongshan, Changsha
2026-07-24
Recruiting
Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasopharyngeal Carcinoma
NCT07528183Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 2
62
Fuzhou, Guangzhou, Nanning, Wuhan
2026-07-22
Recruiting
Efficacy and Safety of Becotatug Vedotin (MRG003) Combined With Anti-PD1 as Maintenance Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma
NCT07705243Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 3
86
Guangzhou
2026-07-20
Recruiting
Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal Carcinoma
NCT07706985Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University
Phase 3
566
Guangzhou
2026-07-20
Not yet open
An Umbrella-designed Prospective Multicenter Randomized Open-label Superiority Trial Evaluating Multi-biomarker-guided Precision Therapy for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma
NCT07709533Valid MeSH Conditions
Sun Yat-sen University
Phase 2
347
Guangdong
2026-07-07
Not yet open
Study on the Effects and Mechanisms of Probiotic Supplementation in Ameliorating Uric Acid Metabolism in Asymptomatic Hyperuricemic Individuals
NCT07650214Asymptomatic Hyperuricemia
Sun Yat-sen University
Not applicable
68
Shenzhen
2026-07-01
Recruiting
Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer
NCT07646301Uterine Cervical Neoplasms, Locally Advanced
Sun Yat-sen University
Phase 2
103
Guangzhou
2026-07-01
Not yet open
New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
NCT07635953Diabetes Mellitus
Sun Yat-sen University
Phase 3
296
Guangzhou
2026-07-01
Not yet open
Trastuzumab Rezetecan(SHR-A1811) Combined With Ivonescimab (AK112) in Locally Advanced or Metastatic Non-small Cell Lung Cancer Harboring HER2 Gene Abnormalities
NCT07630077Non Small Cell Lung Cancer
Sun Yat-sen University
Phase 2
30
Guangzhou
2026-07-01
Not yet open
Rituximab Maintenance Versus Observation After R2 Induction in Previously Untreated Marginal Zone Lymphoma
NCT07654465Marginal Zone Lymphoma(MZL)
Sun Yat-sen University
Phase 2
144
Guangzhou
2026-07
Not yet open
Nudging for Anticoagulation Adherence in Atrial Fibrillation
NCT07543393Atrial Fibrillation (AF)
Sun Yat-sen University
Not applicable
84
Gu'ang'zhou
2026-06-30
Recruiting
Research on Colorectal Cancer Recurrence Monitoring and Individualized Treatment Based on MRD
NCT07775950Colorectal Cancer (MSI-H), Molecular Residual Disease
Sun Yat-sen University
Not applicable
100
Guangzhou
2026-06-23
Recruiting
Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
NCT07638436Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-sen University
Phase 2
42
Guangzhou
2026-06-17
Recruiting
Megestrol Acetate for Fatigue Management in T-DXd Treated Breast Cancer
NCT07543536Advanced/Metastatic Breast Cancer, HER2+, Low, or Ultralow Advanced/Metastatic Breast Cancer
Sun Yat-sen University
Phase 3
132
Guangzhou
2026-06-08
Not yet open
Prospective, Single Arm, Observational Study of Faricimab in the Treatment of Neovascular Age-related Macular Degeneration (nAMD)
NCT07581782Neovascular Age-related Macular Degeneration(nAMD)
Sun Yat-sen University
Observational
50
Guangzhou
2026-06-01
Not yet open
FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)
NCT07621497Metastatic Colorectal Cancer (CRC)
Sun Yat-sen University
Phase 2
229
Guangzhou
2026-06-01
Not yet open
Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma
NCT07542912Complete Remission Rate๏ผŒ CRR, Progression Free Survival, Overall Survival, Adverse Event
Sun Yat-sen University
Not applicable
30
Guangzhou
2026-06-01
Recruiting
Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC
NCT07609121NSCLC (Non-small Cell Lung Cancer)
Sun Yat-sen University
Phase 2
160
Guangzhou
2026-06-01
Recruiting
Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer
NCT07610720Advanced/Metastatic Breast Cancer, HER2-Positive Metastatic Breast Cancer
Sun Yat-sen University
Phase 2
57
Guangdong
2026-06-01
Not yet open
Pirtobrutinib Maintenance After CAR-T Therapy in Relapsed or Refractory B-Cell Lymphoma
NCT07622784Relapsed or Refractory B-cell Lymphoma
Sun Yat-sen University
Phase 2
20
Guangzhou
2026-06
Recruiting
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
NCT07584499Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Nasopharyngeal Carcinoma, Lymphoepithelial Carcinoma, Rhabdomyosarcoma
Sun Yat-sen University
Phase 1
51
Guangzhou
2026-05-30
Not yet open
Lisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma
NCT07601607Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Sun Yat-sen University
Phase 1/2
51
Guangzhou
2026-05-30
Not yet open
Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell Lymphoma
NCT07615283Relapsed or Refractory Peripheral T Cell Lymphoma, NKTCL
Sun Yat-sen University
Phase 1/2
40
Guangzhou
2026-05-29
Recruiting
Neoadjuvant Radiotherapy Combined With NALIRIFOX and Adebrelimab in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Randomized, Phase II Clinical Trial
NCT07622771Rectal Cancers
Sun Yat-sen University
Phase 2
84
Guangzhou
2026-05-26
Not yet open
AI-Assisted Optimization of Online Adaptive Radiotherapy for Gastric Lymphoma
NCT07609355Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)
Sun Yat-sen University
Not applicable
25
Guangzhou
2026-05-08
Not yet open
GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.
NCT07540390Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
442
Guangzhou
2026-05-08
Not yet open
Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma
NCT07567742Oral Mucositis (Ulcerative) Due to Radiation, Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University
Phase 2
130
Guangzhou
2026-05-06
Not yet open
A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma
NCT07574528NKTCL
Sun Yat-sen University
Phase 2
47
Guangzhou
2026-05-06
Not yet open
Phosphate-Containing Replacement Fluid for Patients Undergoing CRRT
NCT07550894Acute Kidney Injury, Sepsis, Critically Ill Patients Requiring Continuous Renal Replacement Therapy
Sun Yat-sen University
Phase 3
220
Chongqing, Guangzhou, Nanning, Luoyang, Zhengzhou, Wuhan, Nanjing, Xi'an
2026-05-01
Not yet open
The Experience of Short Video Addiction Among College Students
NCT07574021Behavior, Addictive, College Student
Sun Yat-sen University
Observational
30
Guangzhou
2026-05-01
Not yet open
Goniotomy in Primary Congenital Glaucoma
NCT07550868Primary Congenital Glaucoma, Goniotomy
Sun Yat-sen University
Observational
120
Guangzhou
2026-05
Not yet open
Becotatug Vedotin Combined With Pucotenlimab as Neoadjuvant Therapy for Resectable Recurrent Head and Neck Squamous Cell Carcinoma After Progression on Immunotherapy: A Prospective Phase II Study
NCT07589049Head and Neck Squamous Cell Carcinoma
Sun Yat-sen University
Phase 2
42
Foshan, Guangzhou, Qingyuan, Shantou, Shenzhen, Zhanjiang, Ganzhou
2026-05
By invitation
BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression
NCT07618624Recurrent Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer
Sun Yat-sen University
Phase 2
42
Foshan, Guangzhou, Shantou, Shenzhen, Zhanjiang
2026-04-20
Recruiting
Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer
NCT07528209Rectal Cancer, pMMR (Microsatellite Stable Rectal Cancer)
Sun Yat-sen University
Phase 3
556
Guangzhou
2026-04-20
Recruiting
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC
NCT07235319Nasopharangeal Cancer, Distant Metastasis
Sun Yat-sen University
Phase 3
260
Guangzhou, Changsha, Fuzhou, Hangzhou, Nanning
2026-04-16
Not yet open
Effects and Mechanisms of Dietary Carbohydrate Intake and Quality on Glucose and Lipid Metabolism
NCT07533513Metabolic Syndrome (MetS), Metabolic Syndrome Risk Factors
Sun Yat-sen University
Not applicable
20
Shenzhen
2026-04-13
Recruiting
QL1706 Plus Lenvatinib in Previously Treated Penile Cancer
NCT07384416Penile Cancer
Sun Yat-sen University
Phase 2
47
Guangzhou
2026-04-10
Not yet open
Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy
NCT07497958Renal Cell Carcinoma (RCC), Renal Function Abnormal
Sun Yat-sen University
Not applicable
174
Guangzhou
2026-04-01
Recruiting
Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer
NCT06768931Breast Cancer, Triple Negative Breast Cancer (TNBC), Early Stage Breast Cancer, Immunotherapy
Sun Yat-sen University
Phase 2
192
Lanzhou, Dongguan, Guangzhou, Zhanjiang, Zigong
2026-04-01
Recruiting
Effects of Different Tunnel Methods in PICC Catheterization
NCT07594704PICC Line Placement, PICC-associated Thrombosis
Sun Yat-sen University
Not applicable
284
Guangzhou
2026-04-01
Recruiting
A Multicenter, Single-Arm, Phase II Exploratory Study of Eribulin in Combination With Anlotinib for HER2-Negative Recurrent/Metastatic Breast Cancer Previously Treated With Antibody-Drug Conjugates
NCT07520760HER 2 Negative Breast Cancer
Sun Yat-sen University
Phase 2
52
Guangzhou
2026-04-01
Recruiting
Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma
NCT07750067Melanoma Metastatic, NRAS Mutation
Sun Yat-sen University
Phase 2
37
Guangzhou
2026-04-01
Not yet open
A Study of Disitamab Vedotin, Tunlametinib, and PD-1 Antibody for Advanced Gastric Cancer
NCT07507526Gastric Adenocarcinoma
Sun Yat-sen University
Phase 2
76
Guangzhou
2026-04
Not yet open
Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer
NCT07469956Pancreatic Cancer Resectable
Sun Yat-sen University
Phase 2
30
Guangzhou
2026-03-31
Recruiting
Efficacy and Safety of Chidamide+Sintilimab+Bev as Second-Line Therapy in Advanced Extrapulmonary Neuroendocrine Carcinoma
NCT07518602Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)
Sun Yat-sen University
Phase 2
34
Guangzhou
2026-03-27
Recruiting
Phase II Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Albumin-Bound Paclitaxel and Lenvatinib as Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer
NCT07530445Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer
Sun Yat-sen University
Phase 2
40
Guangzhou
2026-03-23
Recruiting
Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
NCT07481786Lung Adenocarcinoma, Brain Metastases, Radiotherapy, Intensity-Modulated, Bevacizumab
Sun Yat-sen University
Phase 3
220
Chongqing, Guangzhou
2026-03-20
Recruiting
Radiotherapy After Prostatectomy for Node Positive Prostate Cancer
NCT07477626Prostate Cancer (Post Prostatectomy), Radiotherapy; Image-Guided, Prostate Cancer Non-Metastatic, Androgen Deprivation Therapy
Sun Yat-sen University
Phase 3
372
Dongguan, Guangzhou, Zhanjiang, Zhengzhou, Chengdu, Hangzhou, Beijing, Shanghai
2026-03-20
Recruiting
SBRT Versus Surgical Resection for Small HCC
NCT07381660Hepatocellular Carcinoma (HCC)
Sun Yat-sen University
Phase 3
390
Guangzhou
2026-03-18
Recruiting
Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
NCT07448142Colorectal Cancer (CRC)
Sun Yat-sen University
Phase 2
50
Guangzhou
2026-03-15
Recruiting
Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma
NCT07362979Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 2
243
Dongguan, Guangzhou, Shenzhen, Zhanjiang
2026-03-12
Not yet open
Construction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer
NCT07463690Colorectal Cancer, Stoma
Sun Yat-sen University
Not applicable
200
Guangzhou
2026-03-10
Recruiting
Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL
NCT07494565Diffuse Large B-Cell Lymphoma (DLBCL), CD5 Positive
Sun Yat-sen University
Phase 2
60
Guangzhou
2026-03-06
Recruiting
FMD and Neoadjuvant Chemo-immunotherapy in TNBC
NCT07378306Breast Cancer
Sun Yat-sen University
Phase 2
80
Guangzhou
2026-03-05
Not yet open
ArcFlex Sheath in TAVR Trial
NCT07320274Valve Disease, Aortic
Sun Yat-sen University
Not applicable
180
Guangzhou
2026-03-01
Not yet open
Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study
NCT07398638Diffuse Large B Cell Lymphoma (DLBCL)
Sun Yat-sen University
Phase 1/2
122
Guangzhou
2026-02-28
Recruiting
Theory-Based Parenting Intervention for Preschool Children's Health Behaviors
NCT07458009Preschool Children's Health Behaviors, Parental Support
Sun Yat-sen University
Not applicable
80
Guangzhou
2026-02-28
Not yet open
Surgery With or Without Neoadjuvant Treatment of SBRT Plus Chemoimmunotherapy in Resectable Locally Advanced Oral and HPV-unrelated Oropharyngeal Squamous Cell Carcinoma
NCT07402538Oral Cancer, Oropharyngeal Cancer
Sun Yat-sen University
Phase 3
184
Guangzhou
2026-02-24
Recruiting
Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy
NCT07496190Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 2
59
Guangzhou
2026-02-10
Recruiting
A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma
NCT07392320Nasopharangeal Cancer
Sun Yat-sen University
Phase 2
142
Guangzhou
2026-02-10
Recruiting
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC
NCT07332247Nasopharangeal Cancer, Recurrent Nasopharynx Carcinoma
Sun Yat-sen University
Phase 2
94
Guangzhou
2026-02-03
Not yet open
FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma
NCT07353827Intrahepatic Cholangiocarcinoma (Icc), Hepatic Arterial Infusion Chemotherapy
Sun Yat-sen University
Phase 2
36
Guangzhou
2026-02-01
By invitation
The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia
NCT07515430Acute Lymphoblastic Leukemia
Sun Yat-sen University
Observational
138
Guangzhou
2026-02-01
Not yet open
TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors
NCT07342738KRAS G12V, KRAS G12D, Solid Tumor
Sun Yat-sen University
Phase EARLY_PHASE1
25
Guangzhou
2026-02-01
Not yet open
Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT07388758Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University
Phase 2
37
Guangzhou
2026-02
Active, closed
Toripalimab Plus Bevacizumab Combined Three Intra-arterial Therapies (TACE, HAIC, or TACE-HAIC) for Unresectable Hepatocellular Carcinoma: a Phase 2, Multicenter Randomised Non-comparative Trial
NCT07380633Hepatocellular Carcinoma (HCC)
Sun Yat-sen University
Phase 2
90
Guangzhou
2026-01-23
Recruiting
Sintilimab Plus Bevacizumab Biosimilar as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma
NCT07324824Hepatocellular Carcinoma, Neoadjuvant Therapy, Sintilimab, Bevacizimab
Sun Yat-sen University
Phase 2
37
Guangzhou
2026-01-14
Recruiting
LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC
NCT07325539Nasopharyngeal Cancinoma (NPC), Nasopharangeal Cancer
Sun Yat-sen University
Phase 2
55
Guangzhou, Shenzhen
2026-01-12
Not yet open
A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer
NCT07235618Locally Advanced or Metastatic Breast Cancer
Sun Yat-sen University
Phase 2
50
Guangzhou
2026-01-05
Recruiting
Efficacy and Safety Comparison Between Intensified Therapy and Conversion Therapy For Advanced HCC After Failure of First-line
NCT07501351Hepatocellulcar Carcinoma
Sun Yat-sen University
Phase 2
80
Guangzhou
2026-01-05
Recruiting
Magnetic Tracking and ECG-Guided Tip Confirmation System for PICCs
NCT07369427Peripherally Inserted Central Catheters
Sun Yat-sen University
Observational
176
Guangzhou
2026-01-01
Recruiting
A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer
NCT07103395Lung Cancer (NSCLC)
Sun Yat-sen University
Phase 2
56
Guangzhou
2026-01-01
Not yet open
A Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line and Beyond Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NCT07354984Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Sun Yat-sen University
Phase 2
30
Guangzhou
2026-01-01
Not yet open
Effect of Intrathecal Morphine on Quality of Recovery After Laparoscopic Gynecological Surgery
NCT07322029Laparoscopic Gynecological Surgery
Sun Yat-sen University
Not applicable
252
Guangdong
2026-01
Not yet open
PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer
NCT07277842Locally Advanced Low Rectal Adenocarcinoma, pMMR (Microsatellite Stable Rectal Cancer)
Sun Yat-sen University
Phase 3
382
Guangzhou
2025-12-29
Rows per page Showing 1–100 of 490
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.